Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07731529

Vivifrail Exercise Program in Nonagenarians: Effects on Function, Muscle, and Cognition

This randomized clinical trial investigates the effects of a home-based multicomponent exercise program (Vivifrail) on physical function, muscle morphology, and cognition in community-dwelling adults aged 90 years and older. Participants are randomized into three groups: Vivifrail at least twice a week, Vivifrail at least three times a week, or a control group. Outcomes are assessed at baseline, 12 weeks, and 24 weeks. The primary outcome is physical function measured by the Short Physical Performance Battery (SPPB).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

90 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Escola de Educação Física, Fisioterapia e Dança (ESEFID/UFRGS) - and participants' homes, Porto Alegre, Rio Grande do Sul, Brazil

Loading trial locations.

About this study

This is a three-arm, parallel-group randomized controlled trial evaluating a home-based multicomponent exercise program based on the Vivifrail protocol in community-dwelling nonagenarians (aged 90 years or older). A total of 54 participants (18 per group) will be randomly allocated to one of three groups: G1, performing the Vivifrail program at least twice a week; G2, performing it at least three times a week; or a control group (GC) maintaining usual activities.

Randomization will be performed using Randomizer software (www.randomizer.org) by an independent researcher not involved in the assessments. Allocation is stratified by sex and by baseline functional level, defined by collapsing the six Vivifrail functional categories into two groups (lower function: Types A, B, and B+; higher function: Types C, C+, and D), to ensure balanced distribution of baseline physical function across the three groups. Each participant is still assigned the individualized Vivifrail training passport corresponding to their specific functional category. Given the autonomous, home-based nature of the intervention, participants and interventionists cannot be blinded; however, outcome assessors remain blinded to group allocation throughout the study.

Assessments occur at three timepoints: baseline (T0), 12 weeks (T1), and 24 weeks (T2). The 24-week intervention is individualized according to each participant's functional profile, determined by the Short Physical Performance Battery (SPPB) and the corresponding Vivifrail training passport.

The primary outcome is physical function measured by the total SPPB score (0-12). Secondary outcomes include mobility (Timed Up and Go and cognitive dual-task cost), handgrip strength, lower-limb power (five-times sit-to-stand with linear encoder), gait speed, balance, muscle morphology of the vastus lateralis (ultrasound), cognition (Mini-Mental State Examination), and change in Vivifrail functional category. Data will be analyzed by intention to treat using generalized estimating equations (GEE), examining the group-by-time interaction.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 90 years or older
  • Living in the community (own or family home)
  • Able to walk independently or with a walking aid (cane or walker), without third-party assistance
  • Minimum cognitive capacity to understand and perform the exercises (MMSE, education-adjusted cutoffs)
  • Adequate home conditions to perform the program
  • Availability of a family member or caregiver to support the sessions
  • Signed informed consent (with legal guardian assistance when needed)

Exclusion criteria

  • - Total inability to walk or permanent bedridden condition
  • Severe cognitive impairment preventing safe understanding and execution of exercises
  • Severe orthopedic, neurological, or rheumatological conditions preventing exercise
  • Concurrent participation in another structured exercise program
  • Anticipated unavailability (relocation, planned hospitalization, or institutionalization) during the intervention
  • Refusal to sign informed consent or absence of a legal guardian when required

Treatment and study plan

Vivifrail multicomponent exercise program

Behavioral

Individualized multicomponent home-based training (strength/power, balance, gait, and flexibility) prescribed according to the participant's Vivifrail functional profile.

Primary outcomes

  1. Change in physical function measured by the Short Physical Performance Battery (SPPB) total score

    Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)

    Total SPPB score ranging from 0 to 12 points (higher scores indicate better lower-extremity physical function), combining balance, gait speed, and chair-stand tests.

Secondary outcomes

  1. Mobility - Timed Up and Go (TUG)

    Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)

    ime in seconds to rise, walk 3 meters, turn, return, and sit.

  2. Mobility under dual task - Cognitive TUG and dual-task cost (DTC%) ·

    Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).

    TUG performed with a concurrent cognitive task; dual-task cost calculated as percentage change relative to single-task TUG.

  3. Handgrip strength

    Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).

    Maximal isometric handgrip strength in kilograms, measured with a Jamar dynamometer.

  4. Lower-limb muscle power - Five-times sit-to-stand

    Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).

    ime in seconds and estimated lower-limb power measured during the five-times sit-to-stand test using a linear encoder.

  5. Gait speed

    Time frame: aseline (T0), 12 weeks (T1), and 24 weeks (T2)).

    Usual gait speed in meters per second.

  6. Balance

    Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).

    Static balance assessed by the SPPB balance component (side-by-side, semi-tandem, and tandem stands).

  7. Change in Vastus Lateralis Muscle Thickness

    Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)

    Vastus lateralis muscle thickness measured by B-mode ultrasound, defined as the distance between the adipose-muscle and muscle-bone interfaces, analyzed in ImageJ by a single trained, blinded assessor.

  8. Change in Vastus Lateralis Echo Intensity (Muscle Quality)

    Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)

    Muscle quality assessed by echo intensity on B-mode ultrasound, expressed in arbitrary units (grayscale, 0-255) via manual region-of-interest analysis in ImageJ, excluding fascia and bone. Higher echo intensity indicates greater intramuscular fat/fibrous infiltration, i.e., poorer muscle quality. Single assessor blinded to group allocation.

  9. Cognition - Mini-Mental State Examination (MMSE)

    Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)

    Global cognitive function measured by the MMSE, using education-adjusted cutoffs.

  10. Change in Vivifrail functional category

    Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)

    Transition across Vivifrail functional categories (Types A, B, B+, C, C+, D) over the intervention period.

Study contacts

Contact information is provided by the study sponsor or research team.

ALESSANDRA Silva QUADROS

CONTACT

[email protected]

+5551991020557

Caroline Pietta Dias, PhD

CONTACT

[email protected]

+55 51 84484400

Sponsors and collaborators

Lead sponsor

Federal University of Rio Grande do Sul

Other

Registry information

Official study title

Effects of a Multicomponent Exercise Program Based on the Vivifrail Protocol on Functional Capacity, Muscle Morphology, and Cognition in Nonagenarians: A Randomized Clinical Trial

Acronym: Vivifrail

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jul 28, 2026
Registry last updated
Jul 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.